You are here

  • Home
  • Archive
  • Volume 11, Issue Suppl 2
  • 782-H Effects of an AI generated personalized neopeptide-based immunotherapy, EVX-01, in combination with pembrolizumab in patients with metastatic melanoma: a clinical trial update

Article metrics

Article menu

Download PDFPDF

Regular Abstracts – Part 2
Clinical Trial In Progress
782-H Effects of an AI generated personalized neopeptide-based immunotherapy, EVX-01, in combination with pembrolizumab in patients with metastatic melanoma: a clinical trial update

 

Online download statistics by month:

Online download statistics by month: December 2023 to June 2025

AbstractFullPdf
Dec 20232801
Jan 20248209
Feb 20242605
Mar 20243803
Apr 20244607
May 20244805
Jun 20242201
Jul 20242402
Aug 20241802
Sep 20242201
Oct 20245802
Nov 20242208
Dec 20242006
Jan 20251805
Feb 2025401
Mar 2025003
Apr 2025001
May 2025005
Jun 2025002
Total476069